Literature DB >> 7904748

Cerebral infarction in association with Ecstasy abuse.

S Manchanda1, M J Connolly.   

Abstract

A previously fit 35 year old man presented with a right hemiparesis and dysphasia 36 hours after abuse of Ecstasy (3,4-methylenedioxymethamphetamine). Computerized axial tomography scan demonstrated an extensive acute left cerebral infarction and carotid digital subtraction angiogram, 2 days after admission, revealed left middle cerebral artery occlusion. There were no other known risk factors and all other investigations were negative. The patient made a partial recovery. We propose an association between Ecstasy abuse and cerebral infarction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7904748      PMCID: PMC2399908          DOI: 10.1136/pgmj.69.817.874

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  6 in total

1.  Caudal thalamic infarction following intranasal methamphetamine use.

Authors:  K Sachdeva; K G Woodward
Journal:  Neurology       Date:  1989-02       Impact factor: 9.910

2.  Intracranial hemorrhage with amphetamine abuse.

Authors:  P Delaney; M Estes
Journal:  Neurology       Date:  1980-10       Impact factor: 9.910

3.  Intracranial hemorrhage associated with amphetamine use.

Authors:  T D'Souza; D Shraberg
Journal:  Neurology       Date:  1981-07       Impact factor: 9.910

4.  Intracerebral haemorrhage and vasculitis secondary to amphetamine use.

Authors:  V Salanova; R Taubner
Journal:  Postgrad Med J       Date:  1984-06       Impact factor: 2.401

5.  Ischemic stroke associated with methamphetamine inhalation.

Authors:  J F Rothrock; R Rubenstein; P D Lyden
Journal:  Neurology       Date:  1988-04       Impact factor: 9.910

6.  Intracranial haemorrhage caused by amphetamine abuse.

Authors:  M P Lessing; N M Hyman
Journal:  J R Soc Med       Date:  1989-12       Impact factor: 18.000

  6 in total
  9 in total

1.  Pathology of deaths associated with "ecstasy" and "eve" misuse.

Authors:  C M Milroy; J C Clark; A R Forrest
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

2.  Cerebrovascular accident following MDMA ingestion.

Authors:  C D Muntan; V Tuckler
Journal:  J Med Toxicol       Date:  2006-03

Review 3.  Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.

Authors:  D I Quinn; A Wodak; R O Day
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 4.  Drug abuse and stroke.

Authors:  Ana Catarina Fonseca; José M Ferro
Journal:  Curr Neurol Neurosci Rep       Date:  2013-02       Impact factor: 5.081

Review 5.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

Review 6.  Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy').

Authors:  U D McCann; S O Slate; G A Ricaurte
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

7.  Acute liver damage and ecstasy ingestion.

Authors:  A J Ellis; J A Wendon; B Portmann; R Williams
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

Review 8.  Nephrotoxic effects of designer drugs: synthetic is not better!

Authors:  Randy L Luciano; Mark A Perazella
Journal:  Nat Rev Nephrol       Date:  2014-03-25       Impact factor: 28.314

9.  Epidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazard.

Authors:  Katherine Esse; Marco Fossati-Bellani; Angela Traylor; Sheryl Martin-Schild
Journal:  Brain Behav       Date:  2011-09       Impact factor: 2.708

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.